BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23982173)

  • 21. EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications.
    Li B; Chng WJ
    J Hematol Oncol; 2019 Nov; 12(1):118. PubMed ID: 31752930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the polycomb repressive complex pathway in the bone marrow resident cells of diffuse large B-cell lymphoma patients.
    Oh EJ; Kim EK; Yang WI; Yoon SO
    Leuk Lymphoma; 2016 Aug; 57(8):1921-32. PubMed ID: 26757888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
    Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
    Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes.
    Cyrus S; Burkardt D; Weaver DD; Gibson WT
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):519-531. PubMed ID: 31724824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development.
    Dauber KL; Perdigoto CN; Valdes VJ; Santoriello FJ; Cohen I; Ezhkova E
    J Invest Dermatol; 2016 Aug; 136(8):1647-1655. PubMed ID: 26994968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.
    Healy E; Mucha M; Glancy E; Fitzpatrick DJ; Conway E; Neikes HK; Monger C; Van Mierlo G; Baltissen MP; Koseki Y; Vermeulen M; Koseki H; Bracken AP
    Mol Cell; 2019 Nov; 76(3):437-452.e6. PubMed ID: 31521505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma.
    Wang L; Zhang X; Jia LT; Hu SJ; Zhao J; Yang JD; Wen WH; Wang Z; Wang T; Zhao J; Wang RA; Meng YL; Nie YZ; Dou KF; Chen SY; Yao LB; Fan DM; Zhang R; Yang AG
    Hepatology; 2014 May; 59(5):1850-63. PubMed ID: 24002871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.
    Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A
    J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.
    Zhang X; Zhao X; Fiskus W; Lin J; Lwin T; Rao R; Zhang Y; Chan JC; Fu K; Marquez VE; Chen-Kiang S; Moscinski LC; Seto E; Dalton WS; Wright KL; Sotomayor E; Bhalla K; Tao J
    Cancer Cell; 2012 Oct; 22(4):506-523. PubMed ID: 23079660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader.
    Potjewyd F; Turner AW; Beri J; Rectenwald JM; Norris-Drouin JL; Cholensky SH; Margolis DM; Pearce KH; Herring LE; James LI
    Cell Chem Biol; 2020 Jan; 27(1):47-56.e15. PubMed ID: 31831267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The central role of EED in the orchestration of polycomb group complexes.
    Cao Q; Wang X; Zhao M; Yang R; Malik R; Qiao Y; Poliakov A; Yocum AK; Li Y; Chen W; Cao X; Jiang X; Dahiya A; Harris C; Feng FY; Kalantry S; Qin ZS; Dhanasekaran SM; Chinnaiyan AM
    Nat Commun; 2014; 5():3127. PubMed ID: 24457600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.
    Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M
    Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis.
    Tanaskovic N; Dalsass M; Filipuzzi M; Ceccotti G; Verrecchia A; Nicoli P; Doni M; Olivero D; Pasini D; Koseki H; Sabò A; Bisso A; Amati B
    Life Sci Alliance; 2022 Aug; 5(8):. PubMed ID: 35422437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.
    Shi J; Wang E; Zuber J; Rappaport A; Taylor M; Johns C; Lowe SW; Vakoc CR
    Oncogene; 2013 Feb; 32(7):930-8. PubMed ID: 22469984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.
    Nagel S; Pommerenke C; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    Oncotarget; 2016 Jul; 7(29):45398-45413. PubMed ID: 27322685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediator complex cooperatively regulates transcription of retinoic acid target genes with Polycomb Repressive Complex 2 during neuronal differentiation.
    Fukasawa R; Iida S; Tsutsui T; Hirose Y; Ohkuma Y
    J Biochem; 2015 Nov; 158(5):373-84. PubMed ID: 26002960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycomb group proteins and MYC: the cancer connection.
    Benetatos L; Vartholomatos G; Hatzimichael E
    Cell Mol Life Sci; 2014 Jan; 71(2):257-69. PubMed ID: 23897499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.
    Mahara S; Lee PL; Feng M; Tergaonkar V; Chng WJ; Yu Q
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3735-44. PubMed ID: 27303043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
    Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
    Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.